Videos

Regado Biosciences, Inc. (NASDAQ: RGDO)

David Mazzo of Regado Biosciences talks to Equities.com about the company's novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications.

Comments